World

Meta ends its DEI programs

Jan 11, 2025

San Francisco [California], January 11: Meta on Friday announced the end of its DEI (Diversity, Equity and Inclusion) programs.
Janelle Gale, Meta's vice president of people, made the announcement at the company's Workplace internal communications forum.
"The legal and policy landscape surrounding diversity, equity and inclusion efforts in the United States is changing," Gale said, adding that given the shifting legal and policy landscape, the company is making the changes.
Among the changes, Meta is ending the company's "Diverse Slate Approach" of considering qualified candidates from underrepresented groups for its open roles. The company is also putting an end to its diversity supplier program and its equity and inclusion training programs. Gale also announced the disbanding of the company's DEI team.
The DEI policy change follows several policy reversals by the company this month. Last week, Meta replaced global affairs chief Nick Clegg with Joel Kaplan, who has longstanding ties to the Republican Party. On Tuesday, Facebook CEO Mark Zuckerberg announced the end of the Third-Party Fact-Checking Program on its platforms.
Source: Xinhua News Agency

More news

Indian Research on Young-Onset Parkinson's Disease Receives Recognition at Global GP2 Conference

Bengaluru (Karnataka) [India], November 13: A study conducted by the Parkinson’s Research Alliance of India (PRAI) on the genetic basis of early-onset Parkinson’s disease (PD) in Indian patients has received international recognition as it won the “Best Poster” award at the Global Parkinson’s Genetics Program (GP2) Annual Conference held in Seoul, South Korea, in October 2026. The Global Parkinson’s Genetics Program (GP2), an initiative under Aligning Science Across Parkinson’s (ASAP), brings together researchers worldwide to advance the understanding of Parkinson’s disease genetics with a focus on populations historically underrepresented in research, and support globally relevant discoveries that can inform future therapeutic strategies.

Nov 13, 2026